» Articles » PMID: 12461565

Lymphoid Malignancies: the Dark Side of B-cell Differentiation

Overview
Journal Nat Rev Immunol
Date 2002 Dec 4
PMID 12461565
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

When the regulation of B-cell differentiation and activation is disrupted, lymphomas and leukaemias can occur. The processes that normally create immunoglobulin diversity might be misdirected, resulting in oncogenic chromosomal translocations that block differentiation, prevent apoptosis and/or promote proliferation. Prolonged or unregulated antigenic stimulation might contribute further to the development and progression of some malignancies. Lymphoid malignancies often resemble normal stages of B-cell differentiation, as shown by molecular techniques such as gene-expression profiling. The similarities and differences between malignant and normal B cells indicate strategies for the treatment of these cancers.

Citing Articles

RIF1 integrates DNA repair and transcriptional requirements during the establishment of humoral immune responses.

Kabrani E, Rahjouei A, Berruezo-Llacuna M, Ebeling S, Saha T, Altwasser R Nat Commun. 2025; 16(1):777.

PMID: 39824820 PMC: 11742068. DOI: 10.1038/s41467-025-56166-5.


Shared genetic architecture between autoimmune disorders and B-cell acute lymphoblastic leukemia: insights from large-scale genome-wide cross-trait analysis.

Yu X, Chen Y, Chen J, Fan Y, Lu H, Wu D BMC Med. 2024; 22(1):161.

PMID: 38616254 PMC: 11017616. DOI: 10.1186/s12916-024-03385-0.


PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.

Fouad F, Eid J Medicine (Baltimore). 2023; 102(20):e33836.

PMID: 37335685 PMC: 10194640. DOI: 10.1097/MD.0000000000033836.


NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma.

Jayawant E, Pack A, Clark H, Kennedy E, Ghodke A, Jones J Front Oncol. 2023; 13:1181660.

PMID: 37333821 PMC: 10272839. DOI: 10.3389/fonc.2023.1181660.


Efficacy of coxsackievirus A21 against drug-resistant neoplastic B cells.

Holmes M, Scott G, Heaton S, Barr T, Askar B, Muller L Mol Ther Oncolytics. 2023; 29:17-29.

PMID: 37077714 PMC: 10106520. DOI: 10.1016/j.omto.2023.03.002.